Drug Safety Publications
| Visscher H, Ross CJ, Rassekh SR, Barhdadi A, Dube MP, Al-Saloos H, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Brown AM, Rogers PC, Phillips MS, Rieder MJ, Carleton BC, Hayden MR. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 2011 Sept 9. [Epub ahead of print PMID: 21900104] | |
| Visscher H, Amstutz U, Sistonen J, Ross CJ, Hayden MR, Carleton BC. Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics. J Cardiovasc Pharmacol 2011 Sep;58(3):228-39. PMID: 21386709 | |
| VanderVaart S, Berger H, Sistonen J, Madadi P, Matok I, Gijsen VM, de Wildt SN, Taddio A, Ross CJ, Carleton BC, Hayden MR, Koren G. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. Ther Drug Monit 2011 Aug;33(4):425-32. PMID: 21743374 | |
| Lam J, Kelly L, Ciszkowski C, Landsmeer ML, Nauta M, Carleton BC, Hayden MR, Madadi P, Koren G. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr 2012 Jan;160(1):33-37. e2. Epub 2011 Aug 31. PMID: 21880331 | |
| Pirmohamed M, Friedmann PS, Molokhia M, Loke YK, Smith C, Phillips E, La Grenade L, Carleton B, Papaluca-Amati M, Demoly P, Shear NH. Phenotype standardization for immune-mediated drug-induced skin injury. Clin Pharmacol Ther 2011 Jun;89(6):896-901. PMID: 21562486 | |
| Castro-Pastrana L, Ghannadan R, Rieder MJ, Dahlke E, Hayden M, Carleton B. Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). J Popul Ther Clin Pharmacol 2011 Mar; 18(1):e106-e120. PMID: 21467602 | |
| Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana L, Rieder MJ. A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol 2011 Mar; 18(1):e121-e133. PMID: 21467603 | |
| Ross CJD, Visscher H, Rassekh SR, Castro-Pastrana L, Shereck E, Carleton B, Hayden MR. Pharmacogenomics of serious adverse drug reactions in pediatric oncology. J Popul Ther Clin Pharmacol 2011 Mar; 18(1):e134-e151. PMID: 21467604 | |
| Brunham LR, Lansberg PJ, Zhang L, Miao F, Carter C, Hovingh GK, Visscher H, Jukema JW, Stalenhoef AF, Ross CJD, Carleton BC, Kastelein JJP, Mayden MR. Differential effect of the rs4149056 variant in SLC01B1 on myopathy associated with simvastatin and atorvastatin. Pharmacogenomics J 2011 [EPub ahead of print PMID 21243006] | |
| Madadi P, Hildebrandt D, Gong IY, Schwarz UI, Ciszkowski C, Ross CJD, Sistonen J, Carleton BC, Hayden MR, Lauwers AE, Koren G. Fatal hydrocodone overdose in child: pharmacogenetics and drug interactions. Pediatrics 2010 Oct; 126(4):e986-9. PMID: 20837591 | |
| Ross CJD, Visscher H, Sistonen J, Brunham LR, Pussegoda K, Loo TT, Rieder MJ, Koren G, Carleton BC, Hayden MR. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. Thyroid 2010 Jul; 20(7):681-7. PMID: 20578893 | |
| Ito S, Carleton BC. Predictive genotype for carbamazepine-induced severe skin reactions. CMAJ May 18 2010; 182(8):804. | |
| Wiens MO, Son WK, Ross C, Hayden M, Carleton B. Cocaine Adulterant Linked to Neutropenia. CMAJ 2010 Jan 12;182(1):57-9. PMID: 19969562 | |
| Ross CJD, Katzov-Eckert H, Dubé MP, Brooks B, Rassekh SR, Barhdadi A, Feroz-Zadac Y, Visscher H, Brown AMK, Rogers PC, Philips MS, Carleton B, Hayden MR. TPMT and COMT genetic variants are predictive for severe hearing loss in children receiving cisplatin chemotherapy. Nat Genet 2009 Dec;41(12):1345-9. PMID: 19898482 | |
| Dormuth CR, Carney G, Carleton BC, Bassett K, Wright JM. Thiazolidinediones and fractures in men and women. Arch Intern Med 2009; 169(15): 1395-402. PMID: 19667303 | |
| Carleton BC, Poole RL, Smith MA, Leeder JS, Ghannadan R, Ross CJD, Philips MS, Hayden MR. Adverse drug reaction active surveillance: developing a national network in Canada’s children’s hospitals. Pharmacoepidemiol Drug Saf 2009 Aug; 18(8): 713-21. PMID: 19507171 | |
| Wong E, Carleton BC, Wright DF, Smith MA, Verbeek L, Hildebrand CA, Stannard P, Vaillancourt R, Eliot-Miller P, Ross CJ, Hayden MR. Genotypic approaches to therapy in children (GATC): using information technology to improve drug safety. Stud Health Technol Inform 2009; 143:209-14. PMID: 19380938 | |
| Madadi P., Ross C.J.D., Hayden M.R., Carleton B.C., Gaedigk A., Leeder S.J., Koren G. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2009;85:31-5. | |
| Etminan M, Carleton BC, Samii A. Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study. J Clin Neurosci 2008;15(5):576-7. PMID: 18343119 | |
| Poole R.L., Carleton B.C. Medication Errors: Neonates, Infants and children are the most vulnerable! J Pediatr Pharmacol Ther 2008;13:65-7. | |
| Samii A, Carleton BC, Etminan M. Statin use and the risk of Parkinson disease: a nested case control study. J Clin Neurosci 2008;15(11):1272-3. PMID: 18823780 | |
| Carleton BC, Smith MA, Gelin MN, Heathcote SC. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol Winter 2007;14(1):e45-57. PMID: 17297195 | |
Innovative Research Leading to Optimal Outcomes
